Drug Safety Recalls
Search 17,936 FDA drug recalls and enforcement actions. Check if medications you use have been recalled for safety reasons.
Search Recalls
Find FDA drug recalls by medication name, reason, or manufacturer. Covers all enforcement actions since 2006.
Browse by Year
View drug recalls by year to see trends in pharmaceutical safety enforcement.
Latest Drug Recalls
Most recently initiated FDA drug safety recalls and enforcement actions.
| Date | Product | Reason | Class | Firm |
|---|---|---|---|---|
| Aug 24, 2026 | Ramipril Capsules USP, 10 mg, packaged in a) 100 Capsules (NDC 76282-673-01) ... | Failed Impurities/Degradation Specifications: OOS result obtained for a process impurity, dicyclo... | Class II | Hikma Pharmaceuticals USA INC. |
| Aug 13, 2026 | Paxil CR, Paroxetine, Extended-Release Tablets, 37.5mg, 30 count bottle, Rx o... | Failed Dissolution Specifications; product failed to meet 24-month stability testing acceptance c... | Class II | Apotex Corp. |
| Aug 12, 2026 | Lactated Ringer's Injection USP, 1000 mL EXCEL container, Rx only, L7500, B. ... | Presence of Particulate matter. | Class I | B BRAUN MEDICAL INC |
| Aug 10, 2026 | Tyenne (tocilizumab-aazg) Injection, 400 mg/20 mL (20 mg/mL), 20 mL vial, Rx ... | Presence of particulate matter:An internal investigation at the firm found the product to contain... | Class I | Fresenius Kabi USA, LLC |
| Aug 10, 2026 | Zicam, Cold Remedy, Medicated Nasal Swabs, With Cooling Menthol & Eucalyptus,... | CGMP Deviations; FDA inspection of the contract manufacturer noted out of limit results for micro... | Class II | Church & Dwight Co., Inc. |
| Aug 7, 2026 | Carbamazepine Tablets, USP, 200mg, packaged in a)1000-count bottles (NDC 5140... | CGMP deviations: tablets with black specks. | Class II | Golden State Medical Supply Inc. |
| Aug 6, 2026 | Levothyroxine Sodium Tablets, USP, 112 mcg (0.112 mg), 1000-count bottles, Rx... | Subpotent Drug | Class II | ACCORD HEALTHCARE, INC. |
| Aug 6, 2026 | Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 1000-count bottles, Rx ... | Subpotent Drug | Class II | ACCORD HEALTHCARE, INC. |
| Aug 6, 2026 | Levothyroxine Sodium Tablets, USP, 100 mcg (0.1 mg), packaged in a) 90-count ... | Subpotent Drug | Class II | ACCORD HEALTHCARE, INC. |
| Aug 6, 2026 | Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg), packaged in a) 90-coun... | Subpotent Drug | Class II | ACCORD HEALTHCARE, INC. |
Recalls by Year
FDA drug recalls initiated per year.
Top Recalling Firms
Companies with the most FDA drug recall actions.
| # | Firm | Recalls |
|---|---|---|
| 1 | Aidapak Services, LLC | 538 |
| 2 | Attix Pharmaceuticals | 470 |
| 3 | King Bio Inc. | 465 |
| 4 | The Compounding Pharmacy of America | 383 |
| 5 | Main Street Family Pharmacy, LLC | 299 |
| 6 | Pharmedium Services, LLC | 282 |
| 7 | Central Admixture Pharmacy Services, Inc. | 275 |
| 8 | Cardinal Health Inc. | 213 |
| 9 | Franck's Lab Inc., d.b.a. Franck's Compounding Lab | 198 |
| 10 | Teva Pharmaceuticals USA | 196 |
| 11 | Akorn, Inc. | 176 |
| 12 | Dr. Reddy's Laboratories, Inc. | 163 |
| 13 | Mckesson Medical-Surgical Inc. Corporate Office | 157 |
| 14 | Glenmark Pharmaceuticals Inc., USA | 141 |
| 15 | First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy | 140 |
How It Works
Search Drug Recalls
Enter a medication name, active ingredient, or manufacturer. Our database covers every FDA drug enforcement action from 2006 to 2026.
Review the Details
See the full recall information including classification level, reason for recall, recalling firm, and whether the medication poses serious health risks.
Take Action
If you have a recalled medication, contact your healthcare provider for alternatives. Check the recall details for instructions on returning or disposing of the medication.
Frequently Asked Questions
An FDA drug recall is an action taken to remove a medication from the market because it may be defective, contaminated, improperly manufactured, or mislabeled. Recalls can be initiated voluntarily by the manufacturer or requested by the FDA. Common reasons include cGMP violations, impurity contamination (such as NDMA or other nitrosamines), potency issues, failed sterility testing, and labeling errors.
The FDA classifies drug recalls into three levels. Class I is the most serious, the product may cause serious adverse health consequences or death. Class II means the product may cause temporary or medically reversible adverse health effects. Class III is the least serious, the product is unlikely to cause adverse health effects.
Do not stop taking critical medications abruptly without consulting your doctor. Contact your healthcare provider for guidance on alternatives. Return recalled medication to the pharmacy for a refund. Report adverse reactions to the FDA through their MedWatch program.
All drug recall data comes from the U.S. FDA through the openFDA enforcement database. We maintain 17,936 drug safety records from 2006 to 2026.